Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Duke University Health System Sequencing Clinic, |
RCV003223545 | SCV003919085 | uncertain significance | Seizure | 2023-04-20 | criteria provided, single submitter | research | |
Ambry Genetics | RCV004285599 | SCV004962699 | uncertain significance | not specified | 2023-09-26 | criteria provided, single submitter | clinical testing | The c.2186G>A (p.R729Q) alteration is located in exon 11 (coding exon 11) of the TACC1 gene. This alteration results from a G to A substitution at nucleotide position 2186, causing the arginine (R) at amino acid position 729 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |